Release Date: 26/07/11 10:15 Summary: Quarterly Activities and Cashflow Reports Price Sensitive: Yes Download Document 747.87KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%